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When resources are short, growing 
organisms face an existential choice: 
should you ignore the shortage and 
hope for better times soon, or scale 
back and live within your limited 
means? And if you do scale back, will 
there be any payoff later in life? For 
animals, these choices are played 
out hormonally, with environmental 
fluctuations leading to internal 
rearrangements in endocrine signal 
and response throughout the growing 
body.
In mammals, two principal 
hormones—growth hormone (GH) 
and insulin-like growth factor 1 (IGF-
1)—promote growth. Remarkably, 
inhibiting one or both of these two not 
only retards growth, but also extends 
lifespan, not just in lab animals, but 
possibly also in people: mutations 
that reduce the function of the IGF-1 
receptor have recently been discovered 
in centenarians (who are also short). 
Growth occurs throughout the body, 
and receptors for IGF-1 are found in 
every organ on virtually every cell. But 
Laurent Kappeler et al. now show that 
it is the IGF-1 receptors in the brain 
that set the pattern for growth and 
lifespan.
The authors were led to the brain by 
the hierarchy of the endocrine system 
itself. While the pituitary gland, which 
sits just beneath the cranium, is often 
called the “master gland,” it is really 
more of a first mate, taking its orders 
directly from the brain’s hypothalamus. 
The hypothalamus controls 
differentiation and daily function of 
the pituitary, sending it instructions 
in the form of “releasing hormones,” 
including growth hormone releasing 
hormone (GHRH). The pituitary, in 
turn, releases its own corresponding 
hormones into the blood stream, 
including growth hormone, which 
travels to the liver, triggering the 
production of IGF-1. Collectively, this 
cascade is known as the “somatotropic 
axis,” and the authors reasoned that if 
the axis is ultimately controlled from 
the brain, then its ability to respond to 
resource fluctuations might be found 
there as well.
To test this, they selectively knocked 
out IGF-1 receptors in the brains of 
mice, leaving peripheral receptors 
(including those in the pituitary) 
alone. While homozygous knockouts—
missing both gene copies, and 
producing no brain receptors—had 
significant developmental defects, the 
heterozygotes, which had one normal 
and one missing copy,  were healthy 
and behaved normally. But by 20 days 
after birth, the knockout mice lagged 
in growth, and by 90 days, had fallen 
behind by 10% in body weight and 5% 
in length compared with their normal 
littermates.
Despite normal levels of IGF-1 
receptors on the pituitary, the size of 
the gland was reduced, and its ability 
to produce GH was correspondingly 
smaller. In the hypothalamus, 
production of GHRH was diminished, 
although somatostatin, a hormone 
with opposite effects, continued to be 
produced normally. While most organs 
were smaller than normal, fat tissue 
was increased, likely as a consequence 
of reduced GH. The effects of IGF-1 
receptor knockout did not extend to 
other hormonal control axes—both 
gonadal and thyroidal functions 
remained normal, emphasizing the 
specificity of reduced IGF-1 stimulation.
Mean lifespan was also increased 
in the knockout mice, by about 10%. 
The effect on lifespan was curious, 
however. While the mean was 
extended, the maximum was not—
more knockout mice lived longer, but 
the oldest knockout mouse lived no 
longer than the oldest normal mouse. 
The increased mean lifespan can be 
explained by low peripheral GH and 
IGF-I, which is itself a consequence 
of reduced central IGF sensitivity, in 
keeping with previous studies that 
have shown that reduced peripheral 
IGF-I and GH extend lifespan. 
The reason for the second effect 
(unchanged maximum lifespan) 
is unclear and will require more 
investigation.
These results suggest that IGF-1 
feedback onto the hypothalamus 
during development plays a key role 
in determining the set-point of the 
somatotropic axis throughout life. 
While previous experiments have 
implicated IGF-1 suppression in 
lifespan extension, this study shows 
that central, rather than peripheral, 
suppression is sufficient to trigger the 
effect. Longer lifespan can also be the 
consequence of caloric restriction, 
and these results may indicate one 
mechanism that mediates that 
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phenomenon. They also open the 
door to a multitude of experiments 
to further explore the interplay of 
environment and endocrine control 
in setting the trajectory of metabolism, 
growth, and longevity.
Kappeler L, De Magalhaes Filho C, Dupont 
J, Leneuve P, Cervera P, et al. (2008) Brain 
IGF-1 receptors control mammalian growth 
and lifespan through a neuroendocrine 
mechanism. doi:10.1371/journal.
pbio.0060254